APO RESEARCH · REPORT
Ambulatory Infusion Therapy Services
Infusion therapy involves the administration of medication through a needle or catheter. It is prescribed when a patient’s condition is so severe that it cannot be treated effectively by oral medications.
Product & engineering
Understand the product.
Infusion therapy involves the administration of medication through a needle or catheter. It is prescribed when a patient’s condition is so severe that it cannot be treated effectively by oral medications.
Ambulatory infusion therapy is a flourishing nationwide trend. Due to a confluence of health care trends, such as an upsurge in specialty medications that require expert-level administration, a population increasing in age, and steep health care costs, a challenging, but lucrative opportunity for pharmacies and pharmacists alike has begun to emerge.
Selected research
Industry Research
Ambulatory Infusion Therapy Services Industry Research Report 2026
Market perspective
Infusion therapy involves the administration of medication through a needle or catheter. It is prescribed when a patient’s condition is so severe that it cannot be treated effectively by oral medications.
Ambulatory infusion therapy is a flourishing nationwide trend. Due to a confluence of health care trends, such as an upsurge in specialty medications that require expert-level administration, a population increasing in age, and steep health care costs, a challenging, but lucrative opportunity for pharmacies and pharmacists alike has begun to emerge.
The leading players mainly are Option Care Health, Coram CVS, UnitedHealth Group, HCA Healthcare, McLaren, CHI Health, Accredo Health, PharMerica, Cleveland Clinic, etc. The market is very fragmented because of numerous hospital outpatient infusion services and clinic services
Read the full market overview
Report Scope
This report quantifies the global Ambulatory Infusion Therapy Services market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Ambulatory Infusion Therapy Services.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Ambulatory Infusion Therapy Services Market by Company
Option Care Health
Coram CVS
UnitedHealth Group
HCA Healthcare
McLaren
CHI Health
Accredo Health
PharMerica
Cleveland Clinic
Ambulatory Infusion Therapy Services Segment by Type
Anticoagulation therapy
Chemotherapy
Anti-infective therapies
Hydration therapy
Immune therapy (Ig)
Specialty Injectables
IV Steroids
Wound Care
General Nursing Services
Ambulatory Infusion Therapy Services Segment by Application
Hospital
Clinic
Home
Ambulatory Infusion Therapy Services Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ambulatory Infusion Therapy Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Ambulatory Infusion Therapy Services and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ambulatory Infusion Therapy Services.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Ambulatory Infusion Therapy Services companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Anticoagulation therapy
- Chemotherapy
- Anti-infective therapies
- Hydration therapy
- Immune therapy (Ig)
- Specialty Injectables
- IV Steroids
- Wound Care
- General Nursing Services
Applications
- Hospital
- Clinic
- Home
Companies covered
- Option Care Health
- Coram CVS
- UnitedHealth Group
- HCA Healthcare
- McLaren
- CHI Health
- Accredo Health
- PharMerica
- Cleveland Clinic
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Ambulatory Infusion Therapy Services by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Anticoagulation therapy
- 2.2.3 Chemotherapy
- 2.2.4 Anti-infective therapies
- 2.2.5 Hydration therapy
- 2.2.6 Immune therapy (Ig)
- 2.2.7 Specialty Injectables
- 2.2.8 IV Steroids
- 2.2.9 Wound Care
- 2.2.10 General Nursing Services
- 2.3 Ambulatory Infusion Therapy Services by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Hospital
- 2.3.3 Clinic
- 2.3.4 Home
- 2.4 Assumptions and Limitations
3 Ambulatory Infusion Therapy Services Breakdown Data by Type
- 3.1 Global Ambulatory Infusion Therapy Services Historic Market Size by Type (2021-2026)
- 3.2 Global Ambulatory Infusion Therapy Services Forecasted Market Size by Type (2027-2032)
4 Ambulatory Infusion Therapy Services Breakdown Data by Application
- 4.1 Global Ambulatory Infusion Therapy Services Historic Market Size by Application (2021-2026)
- 4.2 Global Ambulatory Infusion Therapy Services Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Ambulatory Infusion Therapy Services Market Perspective (2021-2032)
- 5.2 Global Ambulatory Infusion Therapy Services Growth Trends by Region
- 5.2.1 Global Ambulatory Infusion Therapy Services Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Ambulatory Infusion Therapy Services Historic Market Size by Region (2021-2026)
- 5.2.3 Ambulatory Infusion Therapy Services Forecasted Market Size by Region (2027-2032)
- 5.3 Ambulatory Infusion Therapy Services Market Dynamics
- 5.3.1 Ambulatory Infusion Therapy Services Industry Trends
- 5.3.2 Ambulatory Infusion Therapy Services Market Drivers
- 5.3.3 Ambulatory Infusion Therapy Services Market Challenges
- 5.3.4 Ambulatory Infusion Therapy Services Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Ambulatory Infusion Therapy Services Players by Revenue
- 6.1.1 Global Top Ambulatory Infusion Therapy Services Players by Revenue (2021-2026)
- 6.1.2 Global Ambulatory Infusion Therapy Services Revenue Market Share by Players (2021-2026)
- 6.2 Global Ambulatory Infusion Therapy Services Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Ambulatory Infusion Therapy Services Head Office and Area Served
- 6.4 Global Ambulatory Infusion Therapy Services Players, Product Type & Application
- 6.5 Global Ambulatory Infusion Therapy Services Manufacturers Established Date
- 6.6 Global Ambulatory Infusion Therapy Services Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Ambulatory Infusion Therapy Services Market Size (2021-2032)
- 7.2 North America Ambulatory Infusion Therapy Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Ambulatory Infusion Therapy Services Market Size by Country (2021-2026)
- 7.4 North America Ambulatory Infusion Therapy Services Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Ambulatory Infusion Therapy Services Market Size (2021-2032)
- 8.2 Europe Ambulatory Infusion Therapy Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Ambulatory Infusion Therapy Services Market Size by Country (2021-2026)
- 8.4 Europe Ambulatory Infusion Therapy Services Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Ambulatory Infusion Therapy Services Market Size (2021-2032)
- 9.2 Asia-Pacific Ambulatory Infusion Therapy Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Ambulatory Infusion Therapy Services Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Ambulatory Infusion Therapy Services Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Ambulatory Infusion Therapy Services Market Size (2021-2032)
- 10.2 South America Ambulatory Infusion Therapy Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Ambulatory Infusion Therapy Services Market Size by Country (2021-2026)
- 10.4 South America Ambulatory Infusion Therapy Services Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Ambulatory Infusion Therapy Services Market Size (2021-2032)
- 11.2 Middle East & Africa Ambulatory Infusion Therapy Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Ambulatory Infusion Therapy Services Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Ambulatory Infusion Therapy Services Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Option Care Health
- 12.1.1 Option Care Health Company Information
- 12.1.2 Option Care Health Business Overview
- 12.1.3 Option Care Health Revenue in Ambulatory Infusion Therapy Services Business (2021-2026)
- 12.1.4 Option Care Health Ambulatory Infusion Therapy Services Product Portfolio
- 12.1.5 Option Care Health Recent Developments
- 12.2 Coram CVS
- 12.2.1 Coram CVS Company Information
- 12.2.2 Coram CVS Business Overview
- 12.2.3 Coram CVS Revenue in Ambulatory Infusion Therapy Services Business (2021-2026)
- 12.2.4 Coram CVS Ambulatory Infusion Therapy Services Product Portfolio
- 12.2.5 Coram CVS Recent Developments
- 12.3 UnitedHealth Group
- 12.3.1 UnitedHealth Group Company Information
- 12.3.2 UnitedHealth Group Business Overview
- 12.3.3 UnitedHealth Group Revenue in Ambulatory Infusion Therapy Services Business (2021-2026)
- 12.3.4 UnitedHealth Group Ambulatory Infusion Therapy Services Product Portfolio
- 12.3.5 UnitedHealth Group Recent Developments
- 12.4 HCA Healthcare
- 12.4.1 HCA Healthcare Company Information
- 12.4.2 HCA Healthcare Business Overview
- 12.4.3 HCA Healthcare Revenue in Ambulatory Infusion Therapy Services Business (2021-2026)
- 12.4.4 HCA Healthcare Ambulatory Infusion Therapy Services Product Portfolio
- 12.4.5 HCA Healthcare Recent Developments
- 12.5 McLaren
- 12.5.1 McLaren Company Information
- 12.5.2 McLaren Business Overview
- 12.5.3 McLaren Revenue in Ambulatory Infusion Therapy Services Business (2021-2026)
- 12.5.4 McLaren Ambulatory Infusion Therapy Services Product Portfolio
- 12.5.5 McLaren Recent Developments
- 12.6 CHI Health
- 12.6.1 CHI Health Company Information
- 12.6.2 CHI Health Business Overview
- 12.6.3 CHI Health Revenue in Ambulatory Infusion Therapy Services Business (2021-2026)
- 12.6.4 CHI Health Ambulatory Infusion Therapy Services Product Portfolio
- 12.6.5 CHI Health Recent Developments
- 12.7 Accredo Health
- 12.7.1 Accredo Health Company Information
- 12.7.2 Accredo Health Business Overview
- 12.7.3 Accredo Health Revenue in Ambulatory Infusion Therapy Services Business (2021-2026)
- 12.7.4 Accredo Health Ambulatory Infusion Therapy Services Product Portfolio
- 12.7.5 Accredo Health Recent Developments
- 12.8 PharMerica
- 12.8.1 PharMerica Company Information
- 12.8.2 PharMerica Business Overview
- 12.8.3 PharMerica Revenue in Ambulatory Infusion Therapy Services Business (2021-2026)
- 12.8.4 PharMerica Ambulatory Infusion Therapy Services Product Portfolio
- 12.8.5 PharMerica Recent Developments
- 12.9 Cleveland Clinic
- 12.9.1 Cleveland Clinic Company Information
- 12.9.2 Cleveland Clinic Business Overview
- 12.9.3 Cleveland Clinic Revenue in Ambulatory Infusion Therapy Services Business (2021-2026)
- 12.9.4 Cleveland Clinic Ambulatory Infusion Therapy Services Product Portfolio
- 12.9.5 Cleveland Clinic Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst